Sharps Technology, Inc.

STSS
NASDAQMedical Instruments & Supplies

-57.9%

since IPO

IPO Price

$4.25

Current Price

$1.79

Return

-57.9%

Market Cap

$69.2M

IPO Date

Apr 14, 2022

Lockup End

Oct 11, 2022

Lockup Status

Lockup expired 1296days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-57.9%

Sharps Technology, Inc. (STSS) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

Sharps Technology, Inc. (ticker: STSS) specializes in emergency medical supplies while maintaining strategic capabilities in diagnostic equipment advancement, positioning itself within the Medical Instruments & Supplies sector through reduced procedure time and cost-effective alternatives. The company has developed its operations around better clinical outcomes, creating market differentiation through specialized expertise and project-based contracts that supports sustainable growth and customer relationship development. The company completed its public offering on 2022-04-14, accessing capital markets during customer demand shifts within the Medical Instruments & Supplies landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to emergency medical supplies as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated challenging market conditions requiring strategic adjustments and operational focus to demonstrate value creation potential. Market assessment focuses on the company's reduced procedure time and strategic emphasis on diagnostic equipment advancement as indicators of long-term competitive positioning within the Medical Instruments & Supplies sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires December 02, 2022, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on emergency medical supplies and emphasis on better clinical outcomes, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Medical Instruments & Supplies market landscape.

Performance Overview

Since going public at $4.25 per share on Apr 14, 2022, Sharps Technology, Inc. shares have declined 57.9%, disappointing investors who participated in the IPO. The stock currently trades at $1.79, giving the company a market capitalization of $69.2M.

Lockup Expiration

The lockup period for Sharps Technology, Inc. expired 1296 days ago on Oct 11, 2022. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Sharps Technology, Inc. operates in the Medical Instruments & Supplies sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing STSS as an investment.

Trading History

Sharps Technology, Inc. is actively trading in the public markets with a current share price of $1.79. The company went public at $4.25 per share, representing a decline of 57.9% from the initial offering price. With a current market capitalization of $69.2M, Sharps Technology, Inc. continues to establish its presence as a publicly traded entity in the Medical Instruments & Supplies.

Important Disclaimer

This analysis of Sharps Technology, Inc. (STSS) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

3
Pre-Expiry Average
Minimal
83
Expiry Day
Very High
56
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
MDLNMedline Inc.Medical Instruments & SuppliesDec 17, 2025$29.00$44.24+52.5%
RGNTRegentis Biomaterials Ltd.Medical Instruments & SuppliesDec 4, 2025$8.00$3.00-62.5%
CUPRCuprina Holdings (Cayman) LimitedMedical Instruments & SuppliesApr 10, 2025$4.00$0.28-92.9%
KMTSKestra Medical Technologies, Ltd.Medical Instruments & SuppliesMar 6, 2025$17.00$21.66+27.4%
NNNNAnbio BiotechnologyMedical Instruments & SuppliesFeb 19, 2025$5.00$27.81+456.2%
AVRAnteris Technologies Global Corp.Medical Instruments & SuppliesDec 13, 2024$6.00$5.68-5.3%
ZJYLJin Medical International Ltd.Medical Instruments & SuppliesMar 28, 2023$8.00$2.30-71.3%
COYACoya Therapeutics, Inc.BiotechnologyDec 29, 2022$5.00$4.26-14.8%

Related IPO Analysis

KO
By • Founder & Data Analyst